Qianglan Lu

Nanjing University

H指数:19

被引数:1,154

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase-Separation Engineered Nanomotors Enable Spleen-Tumor Dual Targeting to Reverse T-Cell Exhaustion

相分离工程纳米马达使脾脏肿瘤双重靶向能够逆转T细胞衰竭

ACS Nano

IF16

2026-01-290

PRE

Spatiotemporally delivery of Cas9 ribonucleoprotein/DNAzyme logic systems using near-infrared upconversion nanomachine for precise immunotherapy

时空递送Cas9核糖核蛋白/DNA酶逻辑系统，利用近红外上转换纳米机器进行精确免疫治疗

Acta Pharmaceutica Sinica B

IF14.6

2025-07-090

OAAI

Reactive oxygen species responsive nanomotors for gene edited metabolic disruption and immunotherapy

响应性氧物种响应型纳米马达用于基因编辑代谢紊乱和免疫治疗

NATURE COMMUNICATIONS

IF15.7

2025-05-210

Polyamine-Depleting Hydrogen-Bond Organic Frameworks Unleash Dendritic Cell and T Cell Vigor for Targeted CRISPR/Cas-Assisted Cancer Immunotherapy

多胺耗竭型氢键有机骨架释放树突状细胞和T细胞活力，以用于靶向CRISPR/Cas辅助癌症免疫疗法

ADVANCED MATERIALS

IF26.8

2025-02-190

PRE

Spatiotemporal Delivery of Dual Nanobodies by Engineered Probiotics to Reverse Tumor Immunosuppression via Targeting Tumor-Derived Exosomes

工程益生菌通过靶向肿瘤来源的外泌体时空递送双纳米抗体以逆转肿瘤免疫抑制

ACS NANO

IF16

2024-09-231

PRE

Inhalation of Bioorthogonal Gene-Editable Spiky-Pollen Reprograms Tumor-Associated Macrophages for Lung Cancer Immunotherapy

吸入生物正交基因可编辑的尖花粉重编程肿瘤相关巨噬细胞用于肺癌免疫治疗

ADVANCED FUNCTIONAL MATERIALS

IF19

2024-09-160

PRE

Microfluidic Synthesis of CuH Nanoparticles for Antitumor Therapy through Hydrogen-Enhanced Apoptosis and Cuproptosis

微流控合成CuH纳米颗粒用于通过氢增强的凋亡和cuprocutosis进行抗肿瘤治疗

ACS NANO

IF16

2024-03-1218

PRE

Self-Metallized Whole Cell Vaccines Prepared by Microfluidics for Bioorthogonally Catalyzed Antitumor Immunotherapy

ACS NANO

IF16

2024-03-066

PRE

Self-Generating Gold Nanocatalysts in Autologous Tumor Cells for Targeted Catalytic Immunotherapy

自体肿瘤细胞中自生金纳米催化剂用于靶向催化免疫治疗

ADVANCED HEALTHCARE MATERIALS

IF9.6

2024-03-010

PRE

Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy

逻辑门控肿瘤微环境纳米放大器可靶向递送CRISPR/Cas9用于多模态癌症治疗

ACTA PHARMACEUTICA SINICA B

IF14.6

2024-02-013

OAAI

Tumor-associated miRNAs activated HCR-DNAzyme theranostic nanosystem to trigger innate- and adaptive-immune responses for long-term immunotherapy

CHEMICAL ENGINEERING JOURNAL

IF13.2

2023-10-0120

PRE

Activation of the cGAS-STING pathway combined with CRISPR-Cas9 gene editing triggering long-term immunotherapy

激活cGAS-STING通路结合CRISPR-Cas9基因编辑触发长期免疫治疗

BIOMATERIALS

IF12.9

2022-12-0137

PRE

Targeted Self-assembly of Renal Clearable Cu2-xSe to Induce Lysosome Swelling for Multimodal Imaging Guided Photothermal/Chemodynamic Synergistic Therapy

ADVANCED FUNCTIONAL MATERIALS

IF19

2022-10-1020

PRE

DNAzyme-Assisted Nano-Herb Delivery System for Multiple Tumor Immune Activation

DNAzyme辅助纳米草药递送系统用于多肿瘤免疫激活

SMALL

IF12.1

2022-09-2621

PRE

Synergistic Lysosomal Impairment and ER Stress Activation for Boosted Autophagy Dysfunction Based on Te Double-Headed Nano-Bullets

SMALL

IF12.1

2022-05-299

PRE

SO2 prodrug doped nanorattles with extra-high drug payload for collusion inside and outside photothermal/pH triggered - gas therapy

BIOMATERIALS

IF12.9

2020-10-0164

PRE

Exo/endogenous dual-augmented chemodynamic therapy based on bioreducible and bio-breakable copper (∐)-based truncated octahedron

CHEMICAL ENGINEERING JOURNAL

IF13.2

2020-09-0143

PREAI

Boosted photocatalytic activity induced NAMPT-Regulating therapy based on elemental bismuth-humic acids heterojunction for inhibiting tumor proliferation/migration/inflammation

BIOMATERIALS

IF12.9

2020-09-0123

PREAI

Enhanced Bax upregulating in mitochondria for deep tumor therapy based on SO2 prodrug loaded Au-Ag hollow nanotriangle

BIOMATERIALS

IF12.9

2020-08-0137

PREAI

Rod-shape inorganic biomimetic mutual-reinforcing MnO2-Au nanozymes for catalysis-enhanced hypoxic tumor therapy

杆状无机仿生相互增强MnO2-Au纳米酶用于催化增强的缺氧肿瘤治疗

NANO RESEARCH

IF9

2020-06-0548

PREAI

Qianglan Lu

个人简介

教育背景

工作经历

荣誉奖项

研究方向